Yurdaydın, CihanWedemeyer, HeinerDalekos, GeorgeErhardt, AlexanderÇakaloğlu, Y.Değertekin, H.Zeuzem, StefanZachou, KalliopiBozkaya, Hakan2022-11-012022-11-012006-10Yurdaydın, C. vd. (2006). ''A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)''. Hepatology, 44(4), Suplement 1, 230A-230A.0270-9139http://hdl.handle.net/11452/29286Bu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyA multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)Meeting Abstract000241362300112230A230A444, Supplement 1Gastroenterology & hepatology